Evidence map›Paper›PMID 41266769›Full record

ArticleCommunications chemistry2025

Accurate predictions of protein mutational effects accelerated with a hybrid-topology free energy protocol.

Lucien Koenekoop, Nadine van de Brug, Willem Jespers, Johan Åqvist, Hugo Gutiérrez-de-Terán

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lucien KoenekoopDepartment of Cell & Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.
Nadine van de BrugDepartment of Cell & Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.ORCID http://orcid.org/0009-0008-3417-8225
Willem JespersMedicinal Chemistry, Photopharmacology and Imaging, Groningen Research Institute of Pharmacy, Groningen, AV, The Netherlands.ORCID http://orcid.org/0000-0002-4951-9220
Johan ÅqvistDepartment of Cell & Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.
Hugo Gutiérrez-de-TeránDepartment of Cell & Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden. h.g.teran@cinn.es.ORCID http://orcid.org/0000-0003-0459-3491

Funding

Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) 2023.0210Vetenskapsrådet (Swedish Research Council) 2022-03441
6 · The paper itself

Abstract

Quantifying the effects of point mutations is of utmost interest for pharmaceutical and biotechnological applications. Reliable computational methods range from statistical and AI-based to physics-based approaches, with the optimal balance between accurate and fast predictions remaining a challenge. Free energy perturbation (FEP) simulations, a powerful physics-based approach available for decades, constitutes nowadays a method of common application in protein mutational studies. We present QresFEP-2, a novel hybrid-topology FEP protocol benchmarked on a comprehensive protein stability dataset of 10 protein systems, encompassing almost 600 mutations. QresFEP-2 combines excellent accuracy with the highest computational efficiency among available FEP protocols, and its robustness is further validated through comprehensive domain-wide mutagenesis, assessing the thermodynamic stability of over 400 mutations generated by a systematic mutation scan of the 56-residue B1 domain of streptococcal protein G (Gβ1). We also demonstrate the applicability domain of QresFEP-2 on evaluating site-directed mutagenesis effects on protein-ligand binding, tested on a GPCR, as well as on protein-protein interactions examined on the barnase/barstar complex. QresFEP-2 emerges as an open-source, physics-based alternative for advancing protein engineering, drug design, and elucidating the impact of mutations on human health.

Identifiers

PMID41266769
PMCPMC12634679

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.